PTK2 and metastatic neoplasm: Remarkably, previous immunohistochemical analysis of the FAK protein in triple negative breast tumors have correlated high FAK levels with shorter overall survival and progression-free survival in patients with metastatic tumors [30], suggesting that FAK functions in tumor cell migration and metastasis are relevant to invasive disease progression.